Concepedia

Claire Imbratta

CI

Statistics

Publications

7

Citations

273

H-Index

7

Active since

2015

Affiliations

University of Lausanne(Current)

South African Tuberculosis Vaccine Initiative

University of Cape Town

Inserm

Ludwig Cancer Research

Claire Imbratta is an author at University of Lausanne specializing in immunology, oncology, and tumor immunology.

Publications per year

2015–2025

7

Publications

7

Molecular profiling of CD8 T cells in autochthonous melanoma identifies Maf as driver of exhaustion

Marilyn Giordano, Coralie Henin, Julien Maurizio et al. · The EMBO Journal · 2015 · 129 citations

, , +16

CD40 Agonist Restores the Antitumor Efficacy of Anti-PD1 Therapy in Muscle-Invasive Bladder Cancer in an IFN I/II-Mediated Manner

M.M. Leblond, Laure Tillé, Sina Nassiri et al. · Cancer Immunology Research · 2020 · 42 citations

, , +17

c‐Maf enforces cytokine production and promotes memory‐like responses in mouse and human type 2 innate lymphoid cells

Sara Trabanelli, Giuseppe Ercolano, Tania Wyss et al. · The EMBO Journal · 2022 · 35 citations · Full text

, , +17

Maf deficiency in T cells dysregulates Treg - TH17 balance leading to spontaneous colitis

Claire Imbratta, M.M. Leblond, Hanifa Bouzourène et al. · Scientific Reports · 2019 · 25 citations · Full text

, , +17

Live-attenuated Mycobacterium tuberculosis vaccine, MTBVAC, in adults with or without M tuberculosis sensitisation: a single-centre, phase 1b–2a, double-blind, dose-escalation, randomised controlled trial

Angelique Kany Kany Luabeya, Virginie Rozot, Claire Imbratta et al. · The Lancet Global Health · 2025 · 17 citations · Full text

, , +17

1–5 of 7